Skip to main content
Bernhard Hering, MD, Internal Medicine, Minneapolis, MN

Bernhard Josef Hering MD


Professor, Surgery, University of Minnesota Medical School. Preventative Cardiology

Join to View Full Profile
  • 516 Delaware Street SEPWB First floor Clinic 1e UNIV of Minn PhysiciansMinneapolis, MN 55455

  • Phone+1 612-626-6666

  • Fax+1 612-625-8496

Are you Dr. Hering?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 13 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Bernhard Hering, MD is an internist in Minneapolis, Minnesota. He is currently licensed to practice medicine in Minnesota. He is affiliated with M Health Fairview University of Minnesota Medical Center and is a Professor at University of Minnesota Medical School. Preventative Cardiology.

Education & Training

  • University of Giessen Faculty of Medicine
    University of Giessen Faculty of MedicineClass of 1983

Certifications & Licensure

  • MN State Medical License
    MN State Medical License 1998 - 2025

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Penn Study Proves Promising for Type 1 Diabetes Cure
    Penn Study Proves Promising for Type 1 Diabetes CureSeptember 14th, 2020
  • Penn Researchers Advance Potential Cure for Type 1 Diabetes
    Penn Researchers Advance Potential Cure for Type 1 DiabetesSeptember 8th, 2020
  • Researchers Remove the Need for Anti-Rejection Drugs in Transplant Recipients
    Researchers Remove the Need for Anti-Rejection Drugs in Transplant RecipientsAugust 5th, 2019
  • Join now to see all

Grant Support

  • Advancing Transplantation Tolerance in Nonhuman PrimatesUNIVERSITY OF MINNESOTA2023–2028
  • Efalizumab (RAPTIVA) Combined With Sirolimus In Type 1 Diabetic Islet AllograftNational Center For Research Resources2009
  • Clinical Trial: Hokt3g1 (Ala-Ala), Sirolimus And Low Dose Tacrolimus Therapy InNational Center For Research Resources2009
  • PIG To Non-Human Primate Islet XenograftsNational Institute Of Allergy And Infectious Diseases2008–2009
  • Cit-03: Single-Center, Open-Label Clinical Trial Of The Efficacy Of PeritransplaNational Center For Research Resources2007–2009
  • Screening Procedure For Allo-Islet Transplantation ProtocolsNational Center For Research Resources2006–2009
  • Clinical Trial: Hokt3Î|1 (Ala-Ala), Sirolimus And Low Dose Tacrolimus TheraNational Center For Research Resources2008
  • Human Pancreatic Islet Cell ResourcesNational Center For Research Resources2006–2008
  • Advancing Islet Transplants For Type 1 Diabetes CareNational Institute Of Allergy And Infectious Diseases2004–2008
  • Cts-Ipita-Ixa 2007 Joint ConferenceNational Institute Of Allergy And Infectious Diseases2007
  • Hokt3γ1 (Ala-Ala), Sirolimus And Low Dose Tacrolimus Therapy In Type 1 DiabNational Center For Research Resources2007
  • Islet Transplantation In Type 1 Diabetic Patients Using The Edmonton ProtocolNational Center For Research Resources2004–2007
  • Anti-Thymoglobumlin, Cyclosporin And RAD In Islet TransplantNational Center For Research Resources2004–2007
  • Preclinical Models Of Organ &Cell Transplant ToleranceNational Institute Of Diabetes And Digestive And Kidney Diseases2006
  • Mixed Chimerism In Haploidentical Non-Human PrimatesNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2006
  • Human Pancreatic Islet Cell Resources (ICRS)National Center For Research Resources2001–2006
  • Initial VS Delayed Mycophenolate Mofetil In Single-Donor Islet AllotransplantatNational Center For Research Resources2005
  • Human Pancreatic Islet Cell Resources Type 1 DiabetesNational Center For Research Resources2004–2005
  • Hokt3gammal (Ala-Ala) For The Prevention Of Human Islet Allograft FailureNational Center For Research Resources2004–2005
  • Tolerance To Islet Allografts In Type I DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2005
  • Initial Vs. Delayed Mycophenolate Mofetil In Single-Donor Islet AllotransplantanNational Center For Research Resources2004
  • Immunotherapy And Islet Replacement In Early DiabetesNational Center For Research Resources2000–2002